Zanamivir structure
Zanamivir
Colorless Crystalline SolidZanamivir was launched as Relenza in Australia for treatment of human
influenza A and B virus infections. Zanamivir (4-guanidino-Neu5Ac2en) can be
obtained by several similar ways, for instance in seven step synthesis starting
from N-acetyI-D-neuraminic acid. Mechanistically, a key viral surface
glycohydrolase essential for viral replication and disease progression by
catalyzing the cleavage of terminal sialic acid residues from the glycoprotein.
The in vitro ac
Find 2 Related Holders
Shandong Newtime Pharmaceutical Co., Ltd.
China
China
API Registration Country
API Active
-
Founded in:
2001-03-30 -
Country:
China -
Address:
No. 1 North Outer Ring Road, Fei County, Shandong -
Tax NO.:
9137130072755352X1 -
Registered Funds:
358.238 million yuan -
Website:
-
Email:
Simcere Pharmaceutical Co., Ltd.
China
China
API Registration Country
API Active
-
Founded in:
1998-09-10 -
Country:
China -
Address:
No. 99, Huakang Road, Jiangbei New District, Nanjing, Jiangsu Province -
Tax NO.:
91320100135665907G -
Registered Funds:
1.60281382 million yuan -
Website:
-
Email:
Recommended Suppliers of Zanamivir
-
Shandong Airuike Chemical Co., Ltd.
CN1 YR
Contact Supplier -
BOC Sciences
US1 YR
Contact Supplier -
Amitychem
CN1 YR
Contact Supplier -
Hunan D Natural Resource Inc
CN1 YR
Contact Supplier -
Hangzhou Raisun Import & Export Co Ltd
CN1 YR
Contact Supplier